# Probing Charged Higgs Bosons through $H^\pm \to W^\pm A$ Decay in the Type-I Two-Higgs Doublet Model

Preprint · Abdesslam Arhrib, Mohamed Krab, Tanmoy Mondal, Prasenjit Sanyal

- Archive id: arxiv:2610.36780
- Published: 2026-10-27
- arXiv: https://arxiv.org/abs/2610.36780
- Citations: 0
- Source URL: https://arxiv.org/abs/2610.36780
- PDF: https://arxiv.org/pdf/2610.36780
- Provenance: arxiv

## Abstract

A light pseudoscalar lighter than the 125 GeV Higgs boson remains allowed within the type-I Two-Higgs Doublet Model (2HDM), consistent with current collider constraints, including Higgs signal strength measurements and direct searches for additional Higgs bosons. At the Large Hadron Collider (LHC), the light pseudoscalar $A$ can be pair-produced through the undetected decay of the Standard Model-like Higgs boson, $h\_{125} \\to AA$, when this channel is kinematically accessible (i.e., $m\_A \< m\_{h\_{125}}/2$). For the charged scalar $H^\\pm$, once open, the bosonic decay channel $H^\\pm \\to W^{\\pm(\*)} A$ naturally dominates over the fermionic $H^\\pm \\to τ^\\pmν$ and $H^\\pm \\to tb$ channels, while relaxing the existing $H^\\pm$ limits. As a result, we propose searching for the charged Higgs boson through $H^\\pm \\to W^{\\pm(\*)} A$ in the $4b+2j+\\ellν$ final state. This channel is particularly sensitive to moderate-to-large $\\tanβ$ values and provides an excellent complementary probe to searches based on fermionic $H^\\pm$ decays at the LHC. Our collider analysis demonstrates that this channel can probe a substantial region of the type-I 2HDM parameter space at the high-luminosity LHC.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Particle Physics & Beyond the Standard Model](https://space-kitty.com/topics/particle-physics-bsm)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.